BIOLARGO, INC. Contracts & Agreements

2024 Engagement Extension Agreement with CFO (Filed With SEC on August 14, 2024)

BioLargo license to Clyra Medical Technologies, Inc., dated March 1, 2024 (Filed With SEC on April 1, 2024)

Clyra Medical Technologies, Inc. license to BioLargo dated March 1, 2024 (Filed With SEC on April 1, 2024)

Form of Share Exchange Agreement between BioLargo, Inc., and purchasers of Clyra Medical Series A Preferred Stock (Filed With SEC on May 17, 2023)

Form of Share Exchange Agreement between BioLargo, Inc., and purchasers of BioLargo Energy Technologies, Inc. common stock (Filed With SEC on May 17, 2023)

Satisfaction of Convertible Note dated March 8, 2018 (Filed With SEC on March 31, 2023)

Form of indemnity agreement between the Company at its officers and directors (Filed With SEC on March 31, 2023)

Engagement Extension Agreement dated as of March 21, 2023 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on March 27, 2023)

Registration Rights Agreement, dated as of December 13, 2022, by and between BioLargo, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on December 19, 2022)

Purchase Agreement, dated as of December 13, 2022, by and between BioLargo, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on December 19, 2022)

Form of Board Member Agreement (Filed With SEC on November 3, 2022)

Form of Indemnity Agreement (Filed With SEC on November 3, 2022)

Engagement Extension Agreement dated as of March 22, 2022 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on March 24, 2022)

Agreement dated March 1, 2022, by and between Scion Solutions, LLC, Clyra Medical Technologies, Inc., and BioLargo, Inc (Filed With SEC on March 8, 2022)

Agreement dated March 3, 2022, by and between Clyra Medical Technologies, Inc., and BioLargo, Inc (Filed With SEC on March 8, 2022)

Second Amendment dated August 12, 2019, to Promissory Note issued to Chappy Bean, LLC dated September 19, 2018 (Filed With SEC on May 19, 2021)

Amended and restated note issued to Chappy Bean on August 12, 2019 (Filed With SEC on May 19, 2021)

Third Amendment dated August 10, 2020 to Promissory Note issued to Vernal Bay Investments, LLC on September 19, 2018 (Filed With SEC on May 19, 2021)

Third Amendment dated August 10, 2020, to Promissory Note issued to Chappy Bean, LLC dated September 19, 2018 (Filed With SEC on May 19, 2021)

Final Payoff Agreement dated May 17, 2021 to Promissory Note issued to Vernal Bay Investments, LLC on September 19, 2018 (Filed With SEC on May 19, 2021)

Final Payoff Agreement dated May 18, 2021 to Promissory Note issued to Chappy Bean, LLC dated September 19, 2018 (Filed With SEC on May 19, 2021)

Amendment to $50,000 Convertible Note dated March 8, 2018 (Filed With SEC on March 30, 2021)

Warrant issued to $50,000 Convertible Noteholder on March 1, 2020 (Filed With SEC on March 30, 2021)

Engagement Extension Agreement dated as of March 18, 2021 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on March 19, 2021)

Warrant issued in 2020 Unit Offering (Filed With SEC on August 14, 2020)

Amendment dated June 30, 2020 to License Agreement with Clyra Medical Technologies, Inc (Filed With SEC on July 7, 2020)

Amendment dated June 30, 2020 to Consulting Agreement dated December 30, 2015 between Clyra Medical and Beach House Consulting LLC (Filed With SEC on July 7, 2020)

Revolving Line of Credit Agreement dated June 30, 2020, between Clyra Medical and Vernal Bay (Filed With SEC on July 7, 2020)

Security Agreement dated June 30, 2020, between Clyra Medical and Vernal Bay (Filed With SEC on July 7, 2020)

Revolving Line of Credit Note issued by Clyra Medical to Vernal Bay on June 30, 2020 (Filed With SEC on July 7, 2020)

Registration Rights Agreement, dated as of March 30, 2020, by and between BioLargo, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 31, 2020)

Purchase Agreement, dated as of March 30, 2020 by and between BioLargo, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 31, 2020)

Engagement Extension Agreement dated as of February 23, 2020 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on February 27, 2020)

Warrant issued March 2018, expiring March 2023 (Filed With SEC on September 17, 2019)

Form of warrant issued January 2019 to Lincoln Park, expiring January 2024 (Filed With SEC on September 17, 2019)

Warrant issued March 2018, expiring March 2023 (Filed With SEC on August 29, 2019)

Form of warrant issued January 2019 to Lincoln Park, expiring January 2024 (Filed With SEC on August 29, 2019)

$600,000 Promissory note dated August 9, 2019 (Filed With SEC on August 14, 2019)

Warrant to purchase 1.2 million shares issued August 9, 2019 to $600,000 note holder (Filed With SEC on August 14, 2019)

Amendment dated August 12, 2019 to Promissory Note issued to Vernal Bay Investments, LLC on September 19, 2018 (Filed With SEC on August 14, 2019)

Amended and restated note issued to Vernal August 12, 2019 (Filed With SEC on August 14, 2019)

Warrant issued to Vernal August 12, 2019 (Filed With SEC on August 14, 2019)

OID twelve-month promissory note (Filed With SEC on August 2, 2019)

Stock purchase warrant issued to OID twelve-month investors (Filed With SEC on August 2, 2019)

Provenzano Employment Agreement dated May 28, 2019 (Filed With SEC on June 24, 2019)

Lock-Up Agreement dated May 28, 2019 (Filed With SEC on June 24, 2019)

Securities Purchase Agreement by and between BioLargo, Inc., and EMA Financial, LP dated June 4, 2019 (Filed With SEC on June 7, 2019)

10% Convertible Promissory Note issued to EMA Financial, LP dated June 4, 2019 (Filed With SEC on June 7, 2019)

Amendment #1 to the Convertible Note issued on June 4, 2019 to EMA Capital, LP (Filed With SEC on June 7, 2019)

Securities Purchase Agreement by and between BioLargo, Inc., and Crossover Capital dated May 10, 2019 (Filed With SEC on May 15, 2019)

Convertible Promissory Note issued to Crossover Capital dated May 10, 2019 (Filed With SEC on May 15, 2019)

Securities Purchase Agreement by and between BioLargo, Inc., and Bellridge Capital, LP dated April 18, 2019 (Filed With SEC on April 23, 2019)

10% Convertible Promissory Note issued to Bellridge Capital, LP dated April 18, 2019 (Filed With SEC on April 23, 2019)

Amendment dated March 5, 2019 to Promissory Note issued to Vernal Bay Investments, LLC on September 19, 2018 (Filed With SEC on March 8, 2019)

Amendment dated March 5, 2019 to Promissory Note issued to Chappy Bean, LLC on September 19, 2018 (Filed With SEC on March 8, 2019)

Amendment dated March 5, 2019 to Convertible Promissory Note issued to Tangiers Global, LLC dated January 31, 2019 (Filed With SEC on March 8, 2019)

Convertible Promissory Note issued to Tangiers Global, LLC dated January 31, 2019 (Filed With SEC on February 11, 2019)

Stock Purchase Warrant issued to Lincoln Park Capital on January 31, 2019 (Filed With SEC on February 11, 2019)

Engagement Extension Agreement dated as of January 16, 2019 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on January 18, 2019)

January 2019 Amendment to Promissory Note dated December 14, 2017, by and between BioLargo, Inc. and Vista Capital Investments, LLC (Filed With SEC on January 11, 2019)

Convertible Promissory Note issued to Vista Capital Investments LLC dated January 7, 2019 (Filed With SEC on January 11, 2019)

Promissory note dated December 17, 2018, issued by Clyra Medical Technologies, Inc., to Scion Solutions, LLC (Filed With SEC on December 19, 2018)

Closing Agreement between Clyra Medical Technologies, Inc., and Scion Solutions, LLC, dated December 17, 2018 (Filed With SEC on December 19, 2018)

Triton Funds LP Securities Purchase Agreement (Filed With SEC on October 22, 2018)

Convertible Promissory Note issued to Triton Funds LP (Filed With SEC on October 22, 2018)

Stock Purchase Warrant issued to Triton Funds LP (Filed With SEC on October 22, 2018)

Stock Purchase Agreement and Plan of Reorganziation dated September 26, 2018 (Filed With SEC on October 2, 2018)

Promissory note issued by Clyra dated September 26, 2018 (Filed With SEC on October 2, 2018)

Escrow Agreement dated September 26, 2018 (Filed With SEC on October 2, 2018)

Promissory Note issued to Vernal Bay Investments, LLC on September 19, 2018 (Filed With SEC on September 24, 2018)

Stock Purchase Warrant issued to Vernal Bay Investments, LLC on September 19, 2018 (Filed With SEC on September 24, 2018)

Promissory Note issued to Chappy Bean, LLC on September 19, 2018 (Filed With SEC on September 24, 2018)

Stock Purchase Warrant issued to Chappy Bean, LLC on September 19, 2018 (Filed With SEC on September 24, 2018)

Stock Purchase Warrant issued to Vista Capital Investments dated September 12, 2018 (Filed With SEC on September 18, 2018)

Amendment to Promissory Note dated December 14, 2017, by and between BioLargo, Inc. and Vista Capital Investments, LLC (Filed With SEC on September 18, 2018)

Line of credit, matures September 1, 2019 (Filed With SEC on May 14, 2018)

Warrant issued with Line of credit that matures September 1, 2019 (Filed With SEC on May 14, 2018)

$50,000 convertible note, matures March 8, 2020 (Filed With SEC on May 14, 2018)

Form of convertible notes that mature April 20, 2021 (Spring 2018 Offering) (Filed With SEC on May 14, 2018)

Form of warrant issued with Convertible notes that mature April 20, 2021 (Spring 2018 Offering) (Filed With SEC on May 14, 2018)

Amendment to $440,000 convertible notes that matures July 20, 2019 (Filed With SEC on May 14, 2018)

Securities Purchase Agreement dated January 16, 2018, with FirstFire (Filed With SEC on January 17, 2018)

Registration Rights Agreement dated January 16, 2018, with FirstFire (Filed With SEC on January 17, 2018)

Convertible Note dated January 16, 2018, with FirstFire (Filed With SEC on January 17, 2018)

Option to purchase common stock issued to Charles K. Dargan dated December 31, 2017 (Filed With SEC on January 3, 2018)

Engagement Extension Agreement dated as of December 31, 2017 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on January 3, 2018)

Securities Purchase Agreement, dated as of December 14, 2017 by and between BioLargo, Inc. and Vista Capital Investments, LLC (Filed With SEC on December 22, 2017)

Registration Rights Agreement, dated as of December 14, 2017, by and between BioLargo, Inc. and Vista Capital Investments, LLC (Filed With SEC on December 22, 2017)

Note, dated as of December 14, 2017, by and between BioLargo, Inc. and Vista Capital Investments, LLC (Filed With SEC on December 22, 2017)

Amendment, dated as of December 18, 2017, by and between BioLargo, Inc. and Vista Capital Investments, LLC (Filed With SEC on December 22, 2017)

Office lease agreement - Oak Ridge, Tennessee (Filed With SEC on September 8, 2017)

Form of Employment Agreement for Engineering Subsidiary (Filed With SEC on September 8, 2017)

Form of Option Agreement issued to founding Engineering subsidiary employees (Filed With SEC on September 8, 2017)

PURCHASE AGREEMENT (Filed With SEC on August 31, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 31, 2017)

Form of Note issued in Summer 2017 Offering (Filed With SEC on August 14, 2017)

Form of Warrant issued in Summer 2017 Offering (Filed With SEC on August 14, 2017)

Form of One-Year Note issued July 2017 (Filed With SEC on August 14, 2017)

Form of Warrant issued to One-Year Noteholder July 2017 (Filed With SEC on August 14, 2017)

Two-year Note in face amount of $440,000 issued July 2017 (Filed With SEC on August 14, 2017)

STOCK OPTION AGREEMENT (Filed With SEC on May 4, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on May 4, 2017)

LOCK-UP AGREEMENT (Filed With SEC on May 4, 2017)

$300,000 Line of Credit issued June 2016 (Filed With SEC on March 30, 2017)

STOCK OPTION AGREEMENT (Filed With SEC on February 14, 2017)

BioLargo, Inc. Engagement Extension Agreement (Filed With SEC on February 14, 2017)

[FORM OF] CONVERTIBLE PROMISSORY NOTE (Filed With SEC on January 25, 2017)

BIOLARGO, INC. [FORM OF] WARRANT TO PURCHASE COMMON STOCK WITH CALL PROVISION (Filed With SEC on January 25, 2017)

BioLargo, Inc. [FORM OF] Convertible Note (Filed With SEC on January 25, 2017)

BIOLARGO, INC. [FORM OF] WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on January 25, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 14, 2016)

BioLargo, Inc. FORM OF Convertible Note (Filed With SEC on November 14, 2016)

BIOLARGO, INC. [FORM OF] WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on November 14, 2016)

BioLargo, Inc. FORM OF Convertible Note (Filed With SEC on August 15, 2016)

BIOLARGO, INC. [FORM OF] WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on August 15, 2016)

BIOLARGO, INC. [FORM OF] WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 15, 2016)

EXHIBIT A NOTICE OF EXERCISE WARRANT (Filed With SEC on August 15, 2016)

CERTIFICATE OF AMENDMENT OF ARTICLES OF INCORPORATION (Filed With SEC on January 6, 2016)

biolargo, inc. INVESTORS RIGHTS AGREEMENT (Filed With SEC on January 6, 2016)

LICENSE AGREEMENT (Filed With SEC on January 6, 2016)

AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on January 6, 2016)

CONSULTING AGREEMENT (Filed With SEC on January 6, 2016)

NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on October 2, 2015)

BioLargo, Inc. Engagement Extension Agreement (Filed With SEC on October 2, 2015)

CLYRA MEDICAL TECHNOLOGIES, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 31, 2015)

BIOLARGO, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 31, 2015)

BIOLARGO, INC. [FORM OF] WARRANT TO PURCHASE COMMON STOCK WITH CALLABLE PROVISION (Filed With SEC on March 31, 2015)

BIOLARGO, INC. [FORM OF] WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 31, 2015)

STOCK OPTION AGREEMENT (Filed With SEC on March 31, 2015)

INVENTORY AND ACCOUNTS RECEIVABLE LINE OF CREDIT (Filed With SEC on March 31, 2015)

CLYRA MEDICAL TECHNOLOGIES, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 31, 2015)

PROMISSORY NOTE (Filed With SEC on March 31, 2015)

BIOLARGO, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 31, 2015)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on March 31, 2015)

BIOLARGO, INC. SERIES A WARRANT TO PURCHASE COMMON STOCK WITH CALL PROVISION (Filed With SEC on March 31, 2015)

AMENDMENT TO STOCK OPTION AGREEMENT (Filed With SEC on December 31, 2012)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on December 31, 2012)

BIOLARGO, INC. [FORM OF] WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on November 14, 2012)

NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on April 10, 2012)

BioLargo, Inc. Engagement Extension Agreement April 9, 2012 (Filed With SEC on April 10, 2012)

BIOLARGO, INC. FORM OF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on April 6, 2012)

TERMINATION AGREEMENT (Filed With SEC on October 5, 2011)

TERMINATION AGREEMENT (Filed With SEC on August 15, 2011)

CONSULTING AGREEMENT (Filed With SEC on August 15, 2011)

BioLargo, Inc. Engagement Extension Agreement (Filed With SEC on March 23, 2011)

FORMOF CONVERTIBLE NOTE (Filed With SEC on April 6, 2010)

BIOLARGO, INC. FORMOF WARRANT TO PURCHASE COMMON STOCK (EighteenMonth Warrant) (Filed With SEC on April 6, 2010)

BIOLARGO, INC. FORMOF WARRANT TO PURCHASE COMMON STOCK (Thirty-SixMonth Warrant) (Filed With SEC on April 6, 2010)

SUB-LICENSE AGREEMENT (Filed With SEC on March 31, 2010)

Amendment No. 1 to Agreement dated August 19, 2008 (Filed With SEC on March 31, 2010)

SUBLICENSE AGREEMENT (Filed With SEC on March 31, 2010)

AGENCY AGREEMENT (Filed With SEC on March 31, 2010)

BioLargo,Inc. EngagementExtension Agreement (Filed With SEC on February 5, 2010)

CURRENT ASSETS (Filed With SEC on August 14, 2009)

our business plan (Filed With SEC on March 31, 2009)

BioLargo, Inc. Engagement Extension Agreement (Filed With SEC on February 24, 2009)

FORM OF CONVERTIBLE NOTE (Filed With SEC on November 14, 2008)

FORM OF WARRANT TOPURCHASE COMMON STOCK (One-Year Warrant) (Filed With SEC on November 14, 2008)

FORM OF WARRANT TOPURCHASE COMMON STOCK (Three-Year Warrant) (Filed With SEC on November 14, 2008)

FORM OF WARRANT TOPURCHASE COMMON STOCK (Three-year Warrant) (Filed With SEC on November 14, 2008)

AGREEMENT (Filed With SEC on November 14, 2008)

SUBLEASE AGREEMENT (Filed With SEC on November 14, 2008)

CONSULTING AGREEMENT (Filed With SEC on November 12, 2008)

BIOLARGO, INC. (Filed With SEC on November 12, 2008)

FORM OF CONVERTIBLE NOTE (Filed With SEC on April 15, 2008)

FORM OF WARRANT TOPURCHASE COMMON STOCK (Filed With SEC on April 15, 2008)

BioLargo, Inc. Engagement Agreement (Filed With SEC on February 4, 2008)

Amendment No. 2 to Consulting Agreement (Filed With SEC on April 5, 2007)

Amendment No. 3 to Research and Development Agreement (Filed With SEC on April 5, 2007)

Amendment No. 1 to Consulting Agreement (Filed With SEC on December 21, 2006)

Amendment No. 2 to Research and Development Agreement (Filed With SEC on December 21, 2006)

Form of Promissory Note (Filed With SEC on December 4, 2006)

AMENDMENT NO. 3 TO TERM LOAN AGREEMENT (Filed With SEC on October 19, 2006)

EXHIBIT A THIRD AMENDED AND RESTATED CONVERTIBLE TERM NOTE $ 420,000 Chicago, Illinois Originally Executed: June 10, 2003 Amended and Restated Effective: March 30, 2004 Second... (Filed With SEC on October 19, 2006)

RESEARCH AND DEVELOPMENT AGREEMENT (Filed With SEC on August 16, 2006)

AMENDMENT NO. 1 (Filed With SEC on August 16, 2006)

CONSULTING AGREEMENT (Filed With SEC on June 23, 2006)

Category

Industry

Companies

Contracts

BIOLARGO, INC. Contracts & Agreements